Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Transboundary and Emerging Diseases|May 29, 2012
Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease A type in the Republic of KoreaJ H Park, K N Lee, Y J Ko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2020
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 studyP Schmid, R Salgado, Y H Park, et al.
The British Journal of Dermatology|September 16, 2011
Hair greying is associated with active hair growthH I Choi, G I Choi, E K Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2026
Genomic Determinants of Response to Alpelisib Plus Fulvestrant in the SOLAR-1 TrialD Juric, H S Rugo, A Reising, et al.
Frontiers in Immunology|October 9, 2023
Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivoShining Ma, Michelle So, Aazam Ghelani, et al.
Transboundary and Emerging Diseases|November 21, 2012
Outbreaks and diagnosis of foot-and-mouth disease serotype O in the Republic of Korea, April-June 2010J-H Park, K-N Lee, Y-J Ko, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|March 26, 2013
Bovine spongiform encephalopathy surveillance in the Republic of KoreaY H Lee, M J Kim, D S Tark, et al.
ESMO Open|March 12, 2026
A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancerG M Kim, M H Kim, H S Park, et al.
ESMO Open|August 26, 2021
Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11)E H Cho, J-Y Kim, S-A Im, et al.
Nature Cell Biology|August 25, 2009
p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescenceKaori Fujita, Abdul M Mondal, Izumi Horikawa, et al.
Pageof 26